Hygeia Healthcare Holdings Co Ltd
HKEX:6078
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
14.9
49.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hygeia Healthcare Holdings Co Ltd
Cost of Revenue
Hygeia Healthcare Holdings Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
Cost of Revenue
-¥2.8B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Cost of Revenue
-¥10.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-24%
|
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Cost of Revenue
-¥2.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-26%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Cost of Revenue
-¥4.5B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-4%
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Cost of Revenue
-¥2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Cost of Revenue
-¥1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hygeia Healthcare Holdings Co Ltd
Glance View
Hygeia Healthcare Holdings Co., Ltd. operates as a biopharmaceutical company that focuses on the development of new clinical drugs. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-06-29. Through its subsidiaries, the Company mainly operates three segments. The Hospital Business segment provides outpatient and inpatient services for patients through its own hospitals. The Radiotherapy Business segment provides radiotherapy center consulting services, as well as the leasing, sales, disposal, and post-sales repair and maintenance services of radiotherapy equipment. The Hospital Management Service segment provides management related services to other hospitals. The firm conducts its businesses in the domestic market.
See Also
What is Hygeia Healthcare Holdings Co Ltd's Cost of Revenue?
Cost of Revenue
-2.8B
CNY
Based on the financial report for Dec 31, 2023, Hygeia Healthcare Holdings Co Ltd's Cost of Revenue amounts to -2.8B CNY.
What is Hygeia Healthcare Holdings Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-40%
Over the last year, the Cost of Revenue growth was -29%. The average annual Cost of Revenue growth rates for Hygeia Healthcare Holdings Co Ltd have been -45% over the past three years , -40% over the past five years .
You don't have any saved screeners yet
